Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.

Gower N, Feugier P, Westin J, Schiano De Colella JM, Tilly H, Palomba ML, Julia E, Damaj GL, Durand A, Flinn I, Lemonnier F, Morineau N, Ysebaert L, Bartlett N, Thieblemont C, Ribrag V, Gastinne T, Dony A, Fouillet L, Guidez S, Houot R, Da Silva MG, Barnes J, Bijou F, Cartron G, Garcia-Sancho AM, Eradat H, Cheminant M, Guillermo AL, Abrisqueta P, Abraham J, Sarkozy C, Izutsu K, Crochet G, Sehn LH, Gkasiamis A, Yge ML, Chartier L, Fowler N, Xerri L, Salles G, Morschhauser F

Open source

DOI: 10.1182/blood.2026033126
Published: 2026 Jun 18
Container: Blood
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2026033126,
  title = {Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.},
  author = {Gower N and Feugier P and Westin J and Schiano De Colella JM and Tilly H and Palomba ML and Julia E and Damaj GL and Durand A and Flinn I and Lemonnier F and Morineau N and Ysebaert L and Bartlett N and Thieblemont C and Ribrag V and Gastinne T and Dony A and Fouillet L and Guidez S and Houot R and Da Silva MG and Barnes J and Bijou F and Cartron G and Garcia-Sancho AM and Eradat H and Cheminant M and Guillermo AL and Abrisqueta P and Abraham J and Sarkozy C and Izutsu K and Crochet G and Sehn LH and Gkasiamis A and Yge ML and Chartier L and Fowler N and Xerri L and Salles G and Morschhauser F},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2026033126},
  url = {https://doi.org/10.1182/blood.2026033126}
}

RIS

TY  - JOUR
TI  - Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.
AU  - Gower N
AU  - Feugier P
AU  - Westin J
AU  - Schiano De Colella JM
AU  - Tilly H
AU  - Palomba ML
AU  - Julia E
AU  - Damaj GL
AU  - Durand A
AU  - Flinn I
AU  - Lemonnier F
AU  - Morineau N
AU  - Ysebaert L
AU  - Bartlett N
AU  - Thieblemont C
AU  - Ribrag V
AU  - Gastinne T
AU  - Dony A
AU  - Fouillet L
AU  - Guidez S
AU  - Houot R
AU  - Da Silva MG
AU  - Barnes J
AU  - Bijou F
AU  - Cartron G
AU  - Garcia-Sancho AM
AU  - Eradat H
AU  - Cheminant M
AU  - Guillermo AL
AU  - Abrisqueta P
AU  - Abraham J
AU  - Sarkozy C
AU  - Izutsu K
AU  - Crochet G
AU  - Sehn LH
AU  - Gkasiamis A
AU  - Yge ML
AU  - Chartier L
AU  - Fowler N
AU  - Xerri L
AU  - Salles G
AU  - Morschhauser F
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2026033126
UR  - https://doi.org/10.1182/blood.2026033126
ER  -

APA

N, G., P, F., J, W., JM, S. D. C., H, T., ML, P., E, J., GL, D., A, D., I, F., F, L., N, M., L, Y., N, B., C, T., V, R., T, G., A, D., L, F., S, G., R, H., MG, D. S., J, B., F, B., G, C., AM, G., H, E., M, C., AL, G., P, A., J, A., C, S., K, I., G, C., LH, S., A, G., ML, Y., L, C., N, F., L, X., G, S., & F, M. (2026). Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis.. Blood. https://doi.org/10.1182/blood.2026033126

Source records

pubmed · retrieved 2026-09-27T14:35:03.903Z